Radio-guided surgery of differentiated thyroid cancer using 131i or 99mtc-sestamibi

Nuclear Medicine Communications

Volumn 27, Issue 1, 2006, Pages 1-4

  Rubello, Domenico ^a   Salvatori, Massimo ^a   Pelizzo, Maria Rosa ^a   Rampin, Lucia ^a   Fanti, Stefano ^a   Gregianin, Michele ^a   Mariani, Giuliano ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

131I; 99mTc Sestamibi; Differentiated thyroid cancer; Radio guided surgery

Indexed keywords

IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROTROPIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

CANCER SURVIVAL; HUMAN; METASTASIS; PEROPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RADIOLOGY; REVIEW; SURGICAL TECHNIQUE; THYROID CANCER; THYROIDECTOMY; CLINICAL TRIAL; EDITORIAL; SCINTISCANNING; THYROID TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

CLINICAL TRIALS; HUMANS; IODINE RADIOISOTOPES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 33645231923     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200601000-00001     Document Type: Editorial

References (22)

1. Shaha AP. Management of the neck in thyroid cancer. Otorhinolaryngol Clin North Am 1998; 31:823-883.
2. Pelizzo MR, Boschin IM, Toniato A, Pagetta C, Piotto A, Rubello D. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun 2004; 25:547-552.
3. Pelizzo MR, Toniato A, Boschin IM, Piotto A, Nibale O, Rubello D. Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients. Nucl Med Commun 2005; 26:965-968.
4. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-1058.
5. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:1447-1463.
6. Rubello D, Caasara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992; 33:1478-1480.
7. American Joint Committee on Cancer. Thyroid. In: American Joint Committee on Cancer. AJCC cancer staging handbook. 6th ed. New York: Springer; 2002. pp. 89-98.
8. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99:60-66.
9. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998; 83:2675-2860.
10. Cherry SR, Sorenson JA, Phelps ME. The gamma camera: performance characteristics. In: Cherry SR, Sorenson JA, Phelps ME, editors. Physics in nuclear medicine. 3rd ed. Philadelphia, PA: Saunders; 2003. pp. 456-467.
11. Schluter B, Bohuslavizki KH, Beyer W, Plotkin M, Buchert R, Clausen M. Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan. J Nucl Med 2001; 42:71-76.
12. Boz A, Arici C, Güngör F. Gamma probe-guided resection and scanning with Tc-99m MIBI of a local recurrence of follicular thyroid carcinoma. Clin Nucl Med 2001; 26:820-822.
13. 99mTc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med 2002; 29:1201-1205.
14. Voutilainen PE, Multanen MM, Leppaniemi AK. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid 2001; 11:953-957.
15. 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med 2005; 46:28S-37S.
16. Maxon HR, Englaro EE, Thomas SR. Radioiodine-131 therapy for well differentiated thyroid cancer. A quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992; 33:1132-1136.
17. Salvatori M, Rufini V, Reale F, Samanes Gasate AM, Maussier ML, Revelli L, et al. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 2003; 27:770-775.
18. Gulec SA, Eckert M, Woltering EA. Gamma probe-guided node dissection (‘gamma picking’) in differentiated thyroid carcinoma. Clin Nucl Med 2002; 12:859-861.
19. Gallowitsh HJ, Fellinger J, Mikosch P. Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma. Clin Nucl Med 1997; 22:591-592.
20. Rubello D, Mazzarotto R, Casara D. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 1999; 27:431-440.
21. Pelizzo MR, Pavan N, Piotto A, Rampin L, Nibale O, Rubello D. Sestamibi radioguided surgery in iodine-131 negative metastatic thyroid cancer. Eur J Nucl Med Mol Imaging 2005; 46:P607.
22. Franceschi M, Kusic Z, Franceschi D, Luiniac L, Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996; 37:446-451.